Cargando…
Breakthrough SARS-CoV-2 infections, morbidity, and seroreactivity following initial COVID-19 vaccination series and additional dose in patients with SLE in New York City
Autores principales: | Saxena, Amit, Engel, Alexis J, Banbury, Brittany, Hasan, Ghadeer, Fraser, Nicola, Zaminski, Devyn, Masson, Mala, Haberman, Rebecca H, Scher, Jose U, Ho, Gary, Law, Jammie, Rackoff, Paula, Tseng, Chung-E, Belmont, H Michael, Clancy, Robert M, Buyon, Jill P, Izmirly, Peter M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275793/ https://www.ncbi.nlm.nih.gov/pubmed/35856060 http://dx.doi.org/10.1016/S2665-9913(22)00190-4 |
Ejemplares similares
-
Clinical implications of discordance between anti-dsDNA antibodies by multiplex flow immunoassay and Crithidia luciliae assay in a multiethnic racial cohort of patients with SLE
por: Zaminski, Devyn, et al.
Publicado: (2023) -
SLE: reconciling heterogeneity
por: Lockshin, Michael D, et al.
Publicado: (2019) -
Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohort
por: Saxena, Amit, et al.
Publicado: (2021) -
Erythrocyte complement receptor 1 (ECR1) and erythrocyte-bound C4d (EC4d) in the prediction of poor pregnancy outcomes in systemic lupus erythematosus (SLE)
por: Conklin, John, et al.
Publicado: (2022) -
Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York
por: Haberman, Rebecca, et al.
Publicado: (2020)